Tema Obesity & Cardiometabolic ETF (HRTS) Chart & Stock Price History $30.58 +0.29 (+0.96%) As of 01/30/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHoldingsRatings Tema Obesity & Cardiometabolic ETF Stock Price Performance 5 Day Performance+1.73%1 Month Performance+5.92%3 Month Performance-6.28%6 Month Performance-10.72%Year-To-Date Performance+5.92%1 Year Performance-2.24% Receive HRTS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address HRTS Stock Chart for Friday, January, 31, 2025 HRTS Chart by TradingView Tema Obesity & Cardiometabolic ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/30/2025$30.29$30.58+0.96%$30.69$30.405,610 shs$57.80 million01/29/2025$30.23$30.29+0.20%$30.32$29.896,336 shs$57.25 million01/28/2025$30.43$30.23-0.66%$30.42$30.2310,306 shs$57.14 million01/27/2025$30.06$30.43+1.23%$30.47$30.0213,114 shs$57.51 million01/24/2025$29.87$30.06+0.64%$30.12$29.8411,973 shs$56.81 million01/23/2025$29.33$29.87+1.84%$29.87$29.1615,596 shs$56.45 million01/22/2025$29.21$29.33+0.41%$29.42$29.2516,474 shs$55.43 million01/21/2025$28.70$29.21+1.78%$29.26$28.7015,328 shs$55.21 million01/20/2025$28.70$28.70$28.97$28.7010,235 shs$54.24 million01/17/2025$28.89$28.70-0.66%$28.97$28.7010,235 shs$54.24 million Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. 01/16/2025$28.95$28.89-0.21%$28.93$28.744,578 shs$54.60 million01/15/2025$28.67$28.95+0.98%$29.10$28.688,864 shs$54.72 million01/14/2025$29.23$28.67-1.92%$29.25$28.5621,161 shs$54.19 million01/13/2025$28.99$29.23+0.83%$29.23$28.6524,301 shs$55.25 million01/10/2025$29.39$28.99-1.36%$29.61$28.8916,126 shs$54.79 million01/09/2025$29.39$29.39$29.51$29.2723,608 shs$55.55 million01/08/2025$29.39$29.39$29.51$29.2723,608 shs$55.55 million01/07/2025$29.28$29.39+0.38%$29.63$29.357,149 shs$55.55 million01/06/2025$29.39$29.28-0.37%$29.49$29.188,617 shs$55.34 million01/03/2025$29.18$29.39+0.72%$29.50$29.196,322 shs$55.55 million01/02/2025$28.87$29.18+1.07%$29.39$29.079,670 shs$55.15 million01/01/2025$28.87$28.87$29.01$28.7622,404 shs$54.56 million12/31/2024$28.96$28.87-0.31%$29.01$28.7622,404 shs$54.56 million12/30/2024$29.44$28.96-1.63%$29.36$28.8618,161 shs$54.73 million Related Companies Themes Lithium & Battery Metal Miners ETF Stock Price Chart Themes Copper Miners ETF Stock Price Chart Stone Ridge 2060 Inflation Protected Longevity Income ETF Stock Price Chart X-Square Balanced Fund, LLC A Stock Price Chart Stone Ridge 2059 Inflation-Protected Longevity Income ETF Stock Price Chart Ocean Park International ETF Stock Price Chart Themes Robotics & Automation ETF Stock Price Chart Themes Uranium & Nuclear ETF Stock Price Chart ARK 21Shares Active Ethereum Futures Strategy ETF Stock Price Chart Stone Ridge 2061 Inflation Protected Longevity Income ETF Stock Price Chart Receive HRTS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:HRTS) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
